The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Hormone treatment of endometriosis: The estrogenthreshold hypothesis
Abstract
In women with recurrent pelvic pain caused by endometriosis, hormonal therapy with a gonadotropin-releasing hormone agonist is an effective alternative to surgical therapy. The basis for medical treatment of endometriosis is that endometriosis lesions are dependent on estradiol for continued growth. Further, end organ tissue varies in its sensitivity to estradiol. This forms the basis of the estrogen threshold hypothesis, that is, that a concentration of estradiol that will partially prevent bone loss may not stimulate endometrial growth. Thus there is a hierarchy of organ response to estradiol such that calcium metabolism is most sensitive followed by gonadotropin secretion, vaginal epithelial growth, lipid metabolism, and liver protein production. Similarly, breast cancer is most sensitive and endometriosis is least sensitive to estrogen. These differences may allow the design of regimens with a gonadotropin-releasing hormone agonist that maintain a therapeutic response and ameliorate potential adverse effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the current mainstay medication for treating endometriosis and adenomyosis is hormonal drugs that aim to suppress estrogen production (Barbieri, 1992)”
From Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium (2025) · cites this paper as Barbieri, 1992
In the citing paper
“The observed combination of equivalent efficacy and different levels of hypoestrogenic effects between dienogest and LA supports the hypothesis of an optimal 'estrogen window' for endometriosis therapy, which was proposed a number of years ago (Barbieri, 1992(Barbieri, , 1998)).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Barbieri, 1992
In the citing paper
“there is a hypothesis of treatment window, that pharmacologically reduces the estrogen level to a certain level so that the growth of ectopic endometrium is curtailed or contained but the level is not too low to cause any detrimental side-effects due to hypoestrogenism76.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [76]
Citations
Cites
Endocrine treatment of breast cancer in women
SANTEN, R. J., MANNI, A., HARVEY, H., & REDMOND, C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-221 · Cited by 399
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
Henzl, M. R., Corson, S. L., Moghissi, K., Buttram, V. C., Berqvist, C., & Jacobson, J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180805 · Cited by 361
Friedman, A. J., Barbieri, R. L., Doubilet, P. M., Fine, C., & Schiff, I. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59763-5 · Cited by 198
Self-citationCurrent Concepts of Endometriosis
Fox, H., & BUCKLEY, C. H. (1984) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00610-5 · Cited by 110
Telimaa, S. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60364-3 · Cited by 87
Analysis of sequential treatment protocols for endometriosis-associated infertility
Olive, D. L., & Lee, K. L. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90611-3 · Cited by 74
Friedman, A. J. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60568-x · Cited by 70
Cedars, M. I., Lu, J. K. H., Meldrum, D. R., & Judd, H. L. (1990) · PubMed · Cited by 69
Current concepts in endometriosis.
Molgaard, C. A., Al, G., & Gresham, L. (1985) · PubMed Central · Cited by 67
MONROE, S. E., BLUMENFELD, Z., ANDERYKO, J. L., SCHRIOCK, E., HENZL, M. R., & JAFFE, R. B. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1334 · Cited by 66
Research works printed but not linked: 4
- Bergquist, 1985, Human uterine and endometriotic tissue transplanted into nude mice, Am J Pathol, 121, 337
- Chetowski, 1986, Biological effects of transdermal estradiol., J Clin Endocrinol Metab, 314, 1615
- Friedman, 1989, Medical management of uterine leiomyomata: treatment with depot leuprolide: a gonadotropin releasing hormone agonist, Fertil Steril, 5, 241
- Cedars, 1990, Treatment of endometriosis with a long acting GnRH agonist and medroxyprogesterone acetate, Obstet Gynecol, 75, 641
Cited by
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00242 · Cited by 844
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., Diamond, M. P., Surrey, E., Johnson, N. P., Watts, N. B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700089 · Cited by 511
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
Metadata
- Authors
- Barbieri, R. L.
- Affiliations
- State University of New York (US)
- Corresponding author
- Barbieri, Robert L.
- ORCID
- Barbieri, Robert L.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 1992-02
- Volume
- 166
- Issue
- 2
- Pages
- 740-745
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W1990060114
- Cited by
- 335
- References
- 25
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 14 · 2016: 4 · 2015: 13 · 2014: 6 · 2013: 11 · 2012: 9
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, hormone therapy, GnRH agonist, bone loss, calcium metabolism, gonadotropin secretion, lipid metabolism, breast cancer, pelvic pain, adverse effects
- MeSH terms
- Bone and Bones, Calcium, Clinical Protocols, Drug Therapy, Combination, Endometriosis, Estradiol, Female, Humans, Gonadotropin-Releasing Hormone, Ovariectomy, Progestins, Bone Density
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormone treatment of endometriosis: The estrogenthreshold hypothesis. https://app.cochat.ai/papers/10.1016/0002-9378(92)91706-g
- The paper
- Barbieri, R. L. (1992). Hormone treatment of endometriosis: The estrogenthreshold hypothesis. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/0002-9378(92)91706-g
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.